Pyxis Oncology, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
PFIZER INC | 05/13/2025 | 7.03 M | $6.89 M | 0.00% | 11.52% |
LAURION CAPITAL MANAGEMENT LP | 05/15/2025 | 3.63 M | $3.55 M | 0.00% | 5.94% |
BLACKROCK, INC. | 05/02/2025 | 3.27 M | $3.21 M | -2.16% | 5.36% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 2.49 M | $2.44 M | -16.63% | 4.07% |
VANGUARD GROUP INC | 05/09/2025 | 2.44 M | $2.39 M | -0.18% | 3.99% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.11 M | $1.09 M | 2.46% | 1.82% |
TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.10 M | $1.08 M | 100.00% | 1.80% |
PALO ALTO INVESTORS LP | 05/15/2025 | 1.04 M | $1.02 M | 0.00% | 1.70% |
STATE STREET CORP | 05/15/2025 | 932.20 K | $913.46 K | -1.27% | 1.53% |
ABRDN PLC | 05/13/2025 | 913.05 K | $894.69 K | 0.00% | 1.50% |
IKARIAN CAPITAL, LLC | 05/15/2025 | 613.25 K | $600.93 K | 0.00% | 1.00% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 582.14 K | $570.44 K | 98.44% | 0.95% |
683 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 550.00 K | $538.95 K | 32.53% | 0.90% |
MORGAN STANLEY | 05/15/2025 | 446.48 K | $437.51 K | 83.94% | 0.73% |
UBS GROUP AG | 05/13/2025 | 396.84 K | $388.91 K | -11.16% | 0.65% |
PIER 88 INVESTMENT PARTNERS LLC | 05/06/2025 | 390.96 K | $383.10 K | 296.55% | 0.64% |
NORTHERN TRUST CORP | 05/13/2025 | 373.72 K | $366.20 K | -1.29% | 0.61% |
DECHENG CAPITAL LLC | 05/08/2025 | 326.81 K | $320.24 K | 0.00% | 0.54% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 272.77 K | $267.29 K | 0.00% | 0.45% |
BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 181.04 K | $177.40 K | 0.00% | 0.30% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 160.83 K | $157.60 K | -12.92% | 0.26% |
05/12/2025 | 127.30 K | $124.75 K | 100.00% | 0.21% | |
SCHULHOFF & CO INC | 05/07/2025 | 122.00 K | $119.55 K | 0.00% | 0.20% |
MAIA WEALTH LLC | 05/12/2025 | 118.90 K | $12 | 0.00% | 0.19% |
NEWEDGE WEALTH, LLC | 05/09/2025 | 116.01 K | $113.67 K | 0.00% | 0.19% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 115.24 K | $112.92 K | -11.19% | 0.19% |
ROYAL BANK OF CANADA | 05/15/2025 | 96.66 K | $95.00 K | 249.54% | 0.16% |
FMR LLC | 05/12/2025 | 86.66 K | $84.91 K | 2.08% | 0.14% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 84.12 K | $81.00 K | 100.00% | 0.14% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 80.80 K | $79.17 K | -70.08% | 0.13% |
YU FAN | 05/15/2025 | 69.30 K | $67.91 K | 0.00% | 0.11% |
RHUMBLINE ADVISERS | 05/29/2025 | 68.16 K | $66.79 K | 0.45% | 0.11% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 64.89 K | $63.58 K | -4.54% | 0.11% |
CABLE CAR CAPITAL LLC | 05/15/2025 | 61.61 K | $60.37 M | 0.00% | 0.10% |
SEI INVESTMENTS CO | 05/14/2025 | 61.14 K | $59.91 K | 0.00% | 0.10% |
BARCLAYS PLC | 05/15/2025 | 54.11 K | $53.00 K | -29.74% | 0.09% |
QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 45.13 K | $44.22 K | 84.02% | 0.07% |
COMMONWEALTH EQUITY SERVICES, LLC | 05/09/2025 | 43.25 K | $42.00 K | 64.76% | 0.07% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 40.32 K | $39.48 K | -24.97% | 0.07% |
AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 40.27 K | $39.46 K | -19.59% | 0.07% |
VERITION FUND MANAGEMENT LLC | 05/15/2025 | 38.26 K | $37.49 K | 100.00% | 0.06% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 36.52 K | $35.78 K | -67.12% | 0.06% |
CITIGROUP INC | 05/12/2025 | 35.04 K | $34.34 K | -16.75% | 0.06% |
INTECH INVESTMENT MANAGEMENT LLC | 05/20/2025 | 32.17 K | $31.53 K | 43.05% | 0.05% |
CITADEL ADVISORS LLC | 05/15/2025 | 30.90 K | $30.28 K | -27.46% | 0.05% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 29.89 K | $29.29 K | 3.25% | 0.05% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2025 | 29.26 K | $28.67 K | 4.46% | 0.05% |
DEUTSCHE BANK AG\ | 05/09/2025 | 28.39 K | $27.82 K | -6.30% | 0.05% |
JPMORGAN CHASE & CO | 05/12/2025 | 28.14 K | $27.57 K | 3.91% | 0.05% |
CETERA INVESTMENT ADVISERS | 05/06/2025 | 27.86 K | $27.30 K | 3.72% | 0.05% |
Pyxis Oncology, Inc. institutional Ownership - FAQ's
During the previous two years, 108 institutional investors and hedge funds held shares of Pyxis Oncology, Inc.. The most heavily invested institutionals were:
PFIZER INC: 7.03 M
Laurion Capital Management LP: 3.63 M
BlackRock, Inc.: 3.27 M
MILLENNIUM MANAGEMENT LLC: 2.49 M
VANGUARD GROUP INC: 2.44 M
GEODE CAPITAL MANAGEMENT, LLC: 1.11 M
49.47% of Pyxis Oncology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 34.41 M shares in the last 24 months. This purchase volume represents approximately $40.26 M in transactions.